| abstract |
The present invention relates to target binding members (eg, antibodies) that bind to specific epitopes of human IL-25. The invention also relates to a target binding member (eg, an antibody) comprising one or more humanized antibody VL domain sequences and binding to IL-25. The present invention also provides compositions comprising target binding members (eg, antibodies) that bind IL-25, methods of making such target binding members, and treatment of diseases and conditions (eg, asthma, inflammatory bowel disease). Or to the use of such target binding members in prophylaxis. |